{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T20:08:18Z","timestamp":1781554098462,"version":"3.54.5"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T00:00:00Z","timestamp":1542153600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"crossref","award":["2010\/17668-6"],"award-info":[{"award-number":["2010\/17668-6"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00262-018-2273-2","type":"journal-article","created":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T07:00:22Z","timestamp":1542178822000},"page":"269-282","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Targeting the polarization of tumor-associated macrophages and modulating mir-155 expression might be a new approach to treat diffuse large B-cell lymphoma of the elderly"],"prefix":"10.1007","volume":"68","author":[{"given":"Wagner A.","family":"Poles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika E.","family":"Nishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana B.","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela I. P.","family":"Eug\u00eanio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tathiana A.","family":"de Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Hugo F. M.","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Ruy R.","family":"de Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Vassallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio C.","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristovam","family":"Scapulatempo Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto Antonio Pinto","family":"Paes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Landman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cl\u00e1udia N.","family":"Zerbini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7144-4878","authenticated-orcid":false,"given":"Gisele W. B.","family":"Colleoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,14]]},"reference":[{"key":"2273_CR1","unstructured":"Swerdlow SH, World Health Organization (2008) Who Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4. edn, World Health Organization Classification of Tumours. Lyon: International Agency for Research on Cancer (IARC)"},{"issue":"1","key":"2273_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/00000478-200301000-00003","volume":"27","author":"T Oyama","year":"2003","unstructured":"Oyama T, Ichimura K, Suzuki R, Suzumiya J, Ohshima K, Yatabe Y et al (2003) Senile EBV + B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients. Am J Surg Pathol 27(1):16\u201326","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"2273_CR3","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nri2318","volume":"8","author":"J Nikolich-Zugich","year":"2008","unstructured":"Nikolich-Zugich J (2008) Ageing and life-long maintenance of T-cell subsets in the face of latent persistent infections. Nat Rev Immunol 8(7):512\u201322. \n                    https:\/\/doi.org\/10.1038\/nri2318","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"2273_CR4","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1634\/theoncologist.2010-0213","volume":"16","author":"JJ Castillo","year":"2011","unstructured":"Castillo JJ, Beltran BE, Miranda RN, Paydas S, Winer ES, Butera JN (2011) Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly: what we know so far. Oncologist 16(1):87\u201396. \n                    https:\/\/doi.org\/10.1634\/theoncologist.2010-0213","journal-title":"Oncologist"},{"key":"2273_CR5","unstructured":"Nakamura S, Jaffe ES, Swerdlow SH (2008) EBV positive diffuse large B-cell lymphoma of the elderly. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds) WHO classification of tumours of haematopoietic and lymphoid tissues. 4th Lyon: International Agency for Research on Cancer (IARC), pp 243\u2013244"},{"issue":"7","key":"2273_CR6","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/modpathol.2012.52","volume":"25","author":"S Montes-Moreno","year":"2012","unstructured":"Montes-Moreno S, Odqvist L, Diaz-Perez JA, Lopez AB, de Villambrosia SG, Mazorra F et al (2012) EBV-positive diffuse large B-cell lymphoma of the elderly is an aggressive post-germinal center B-cell neoplasm characterized by prominent nuclear factor-kB activation. Mod Pathol 25(7):968\u2013982. \n                    https:\/\/doi.org\/10.1038\/modpathol.2012.52","journal-title":"Mod Pathol"},{"key":"2273_CR7","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1182\/blood-2013-03-489708","volume":"122","author":"CY Ok","year":"2013","unstructured":"Ok CY, Papathomas TG, Medeiros LJ, Young KH (2013) EBV-positive diffuse large B-cell lymphoma of the elderly. Blood 122:328\u2013340","journal-title":"Blood"},{"issue":"23","key":"2273_CR8","doi-asserted-by":"publisher","first-page":"11813","DOI":"10.18632\/oncotarget.2952","volume":"5","author":"TA Andrade","year":"2014","unstructured":"Andrade TA, Evangelista AF, Campos AH, Poles WA, Borges NM, Camillo CM et al (2014) A microRNA signature profile in EBV + diffuse large B-cell lymphoma of the elderly. Oncotarget 5(23):11813\u201311826. \n                    https:\/\/doi.org\/10.18632\/oncotarget.2952","journal-title":"Oncotarget"},{"issue":"2","key":"2273_CR9","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1182\/blood-2012-08-449306","volume":"122","author":"E Zonari","year":"2013","unstructured":"Zonari E, Pucci F, Saini M, Mazzieri R, Politi LS, Gentner B et al (2013) A role for miR-155 in enabling tumor-infiltrating innate immune cells to mount effective antitumor responses in mice. Blood 122(2):243\u2013252. \n                    https:\/\/doi.org\/10.1182\/blood-2012-08-449306","journal-title":"Blood"},{"issue":"11","key":"2273_CR10","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.3109\/10428194.2013.879713","volume":"55","author":"SJ Nam","year":"2014","unstructured":"Nam SJ, Go H, Paik JH, Kim TM, Heo DS, Kim CW et al (2014) An increase of M2 macrophages predicts poor prognosis in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone. Leuk Lymphoma 55(11):2466\u20132476. \n                    https:\/\/doi.org\/10.3109\/10428194.2013.879713","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"2273_CR11","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ccr.2005.08.002","volume":"8","author":"M Palma De","year":"2005","unstructured":"De Palma M, Venneri MA, Galli R, Sergi Sergi L, Politi LS, Sampaolesi M et al (2005) Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 8(3):211\u2013226. \n                    https:\/\/doi.org\/10.1016\/j.ccr.2005.08.002","journal-title":"Cancer Cell"},{"issue":"1","key":"2273_CR12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","volume":"141","author":"BZ Qian","year":"2010","unstructured":"Qian BZ, Pollard JW (2010) Macrophage diversity enhances tumor progression and metastasis. Cell 141(1):39\u201351. \n                    https:\/\/doi.org\/10.1016\/j.cell.2010.03.014","journal-title":"Cell"},{"issue":"11","key":"2273_CR13","doi-asserted-by":"publisher","first-page":"e80908","DOI":"10.1371\/journal.pone.0080908","volume":"8","author":"MH Barros","year":"2013","unstructured":"Barros MH, Hauck F, Dreyer JH, Kempkes B, Niedobitek G (2013) Macrophage polarisation: an immunohistochemical approach for identifying M1 and M2 macrophages. PLoS One 8(11):e80908. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0080908","journal-title":"PLoS One"},{"issue":"14","key":"2273_CR14","doi-asserted-by":"publisher","first-page":"5728","DOI":"10.1158\/0008-5472.CAN-09-4672","volume":"70","author":"K Movahedi","year":"2010","unstructured":"Movahedi K, Laoui D, Gysemans C, Baeten M, Stange G, Van den Bossche J et al (2010) Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. Cancer Res 70(14):5728\u20135739. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-4672","journal-title":"Cancer Res"},{"issue":"5","key":"2273_CR15","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/j.1440-1827.2009.02369.x","volume":"59","author":"K Kawamura","year":"2009","unstructured":"Kawamura K, Komohara Y, Takaishi K, Katabuchi H, Takeya M (2009) Detection of M2 macrophages and colony-stimulating factor 1 expression in serous and mucinous ovarian epithelial tumors. Pathol Int 59 (5):300\u20135. \n                    https:\/\/doi.org\/10.1111\/j.1440-1827.2009.02369.x","journal-title":"Pathol Int"},{"key":"2273_CR16","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/1742-2094-9-222","volume":"9","author":"D Hasan","year":"2012","unstructured":"Hasan D, Chalouhi N, Jabbour P, Hashimoto T (2012) Macrophage imbalance (M1 vs. M2) and upregulation of mast cells in wall of ruptured human cerebral aneurysms: preliminary results. J Neuroinflamm 9:222. \n                    https:\/\/doi.org\/10.1186\/1742-2094-9-222","journal-title":"J Neuroinflamm"},{"issue":"4","key":"2273_CR17","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1093\/ajcp\/aqw034","volume":"145","author":"JC Gomez-Gelvez","year":"2016","unstructured":"Gomez-Gelvez JC, Salama ME, Perkins SL, Leavitt M, Inamdar KV (2016) Prognostic impact of tumor microenvironment in diffuse large B-cell lymphoma uniformly treated with R-CHOP chemotherapy. Am J Clin Pathol 145(4):514\u2013523. \n                    https:\/\/doi.org\/10.1093\/ajcp\/aqw034","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"2273_CR18","doi-asserted-by":"publisher","first-page":"5414","DOI":"10.18632\/oncotarget.14289","volume":"8","author":"J Wang","year":"2017","unstructured":"Wang J, Gao K, Lei W, Dong L, Xuan Q, Feng M et al (2017) Lymphocyte-to-monocyte ratio is associated with prognosis of diffuse large B-cell lymphoma: correlation with CD163 positive M2 type tumor-associated macrophages, not PD-1 positive tumor-infiltrating lymphocytes. Oncotarget 8(3):5414\u20135425. \n                    https:\/\/doi.org\/10.18632\/oncotarget.14289","journal-title":"Oncotarget"},{"issue":"3","key":"2273_CR19","doi-asserted-by":"publisher","first-page":"259","DOI":"10.7785\/tcrt.2012.500312","volume":"12","author":"C Lan","year":"2013","unstructured":"Lan C, Huang X, Lin S, Huang H, Cai Q, Wan T et al (2013) Expression of M2-polarized macrophages is associated with poor prognosis for advanced epithelial ovarian cancer. Technol Cancer Res Treat 12 (3):259\u2013267. \n                    https:\/\/doi.org\/10.7785\/tcrt.2012.500312","journal-title":"Technol Cancer Res Treat"},{"issue":"4","key":"2273_CR20","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/bjc.2013.32","volume":"108","author":"Y Ino","year":"2013","unstructured":"Ino Y, Yamazaki-Itoh R, Shimada K, Iwasaki M, Kosuge T, Kanai Y et al (2013) Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer. Br J Cancer 108(4):914\u2013923. \n                    https:\/\/doi.org\/10.1038\/bjc.2013.32","journal-title":"Br J Cancer"},{"issue":"7","key":"2273_CR21","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.jcms.2014.01.035","volume":"42","author":"M Weber","year":"2014","unstructured":"Weber M, Buttner-Herold M, Hyckel P, Moebius P, Distel L, Ries J et al (2014) Small oral squamous cell carcinomas with nodal lymphogenic metastasis show increased infiltration of M2 polarized macrophages\u2013an immunohistochemical analysis. J Craniomaxillofac Surg 42(7):1087\u20131094. \n                    https:\/\/doi.org\/10.1016\/j.jcms.2014.01.035","journal-title":"J Craniomaxillofac Surg"},{"issue":"14","key":"2273_CR22","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJM199309303291402","volume":"329","author":"International Non-Hodgkin","year":"1993","unstructured":"International Non-Hodgkin\u2019s Lymphoma Prognostic Factors P (1993) A predictive model for aggressive non-Hodgkin\u2019s lymphoma. N Engl J Med 329(14):987\u2013994. \n                    https:\/\/doi.org\/10.1056\/NEJM199309303291402","journal-title":"N Engl J Med"},{"issue":"4","key":"2273_CR23","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4):402\u2013408. \n                    https:\/\/doi.org\/10.1006\/meth.2001.1262","journal-title":"Methods"},{"key":"2273_CR24","first-page":"1","volume":"9","author":"R Goni","year":"2012","unstructured":"Goni R, Garc\u00eda P, Foissac S (2012) The qPCR data statistical analysis. Integromics W P 9:1\u20139","journal-title":"Integromics W P"},{"key":"2273_CR25","volume-title":"Applied statistics for the behavioral sciences","author":"DE Hinkle","year":"2003","unstructured":"Hinkle DE, Wiersma W, Jurs SG (2003) Applied statistics for the behavioral sciences, 5th\u00a0edn. Houghton Mifflin, Boston","edition":"5"},{"key":"2273_CR26","doi-asserted-by":"publisher","first-page":"347137","DOI":"10.1155\/2011\/347137","volume":"2011","author":"SK Sandhu","year":"2011","unstructured":"Sandhu SK, Croce CM, Garzon R (2011) Micro-RNA expression and function in lymphomas. Adv Hematol 2011:347137. \n                    https:\/\/doi.org\/10.1155\/2011\/347137","journal-title":"Adv Hematol"},{"issue":"5","key":"2273_CR27","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/bjh.12157","volume":"160","author":"CH Lawrie","year":"2013","unstructured":"Lawrie CH (2013) MicroRNAs and lymphomagenesis: a functional review. Br J Haematol 160(5):571\u2013581. \n                    https:\/\/doi.org\/10.1111\/bjh.12157","journal-title":"Br J Haematol"},{"issue":"5","key":"2273_CR28","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/sj.leu.2401395","volume":"13","author":"M Wada","year":"1999","unstructured":"Wada M, Okamura T, Okada M, Teramura M, Masuda M, Motoji T et al (1999) Frequent chromosome arm 13q deletion in aggressive non-Hodgkin\u2019s lymphoma. Leukemia 13(5):792\u2013798","journal-title":"Leukemia"},{"issue":"26","key":"2273_CR29","doi-asserted-by":"publisher","first-page":"6681","DOI":"10.1182\/blood-2009-01-202028","volume":"113","author":"C Li","year":"2009","unstructured":"Li C, Kim SW, Rai D, Bolla AR, Adhvaryu S, Kinney MC et al (2009) Copy number abnormalities, MYC activity, and the genetic fingerprint of normal B cells mechanistically define the microRNA profile of diffuse large B-cell lymphoma. Blood 113(26):6681\u20136690. \n                    https:\/\/doi.org\/10.1182\/blood-2009-01-202028","journal-title":"Blood"},{"key":"2273_CR30","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1756-8722-6-16","volume":"6","author":"KY Wong","year":"2013","unstructured":"Wong KY, Yim RL, Kwong YL, Leung CY, Hui PK, Cheung F et al (2013) Epigenetic inactivation of the MIR129-2 in hematological malignancies. J Hematol Oncol 6:16. \n                    https:\/\/doi.org\/10.1186\/1756-8722-6-16","journal-title":"J Hematol Oncol"},{"issue":"6","key":"2273_CR31","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1111\/j.1365-2141.2010.08111.x","volume":"149","author":"JL Robertus","year":"2010","unstructured":"Robertus JL, Kluiver J, Weggemans C, Harms G, Reijmers RM, Swart Y et al (2010) MiRNA profiling in B non-Hodgkin lymphoma: a MYC-related miRNA profile characterizes Burkitt lymphoma. Br J Haematol 149(6):896\u2013899. \n                    https:\/\/doi.org\/10.1111\/j.1365-2141.2010.08111.x","journal-title":"Br J Haematol"},{"issue":"5671","key":"2273_CR32","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1126\/science.1096781","volume":"304","author":"S Pfeffer","year":"2004","unstructured":"Pfeffer S, Zavolan M, Grasser FA, Chien M, Russo JJ, Ju J et al (2004) Identification of virus-encoded microRNAs. Science 304(5671):734\u2013736. \n                    https:\/\/doi.org\/10.1126\/science.1096781","journal-title":"Science"},{"issue":"11\u201312","key":"2273_CR33","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.bbagrm.2011.05.010","volume":"1809","author":"S Barth","year":"2011","unstructured":"Barth S, Meister G, Grasser FA (2011) EBV-encoded miRNAs. Biochim Biophys Acta 1809(11\u201312):631\u2013640. \n                    https:\/\/doi.org\/10.1016\/j.bbagrm.2011.05.010","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"2273_CR34","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/modpathol.2016.199","volume":"30","author":"J Morscio","year":"2017","unstructured":"Morscio J, Finalet Ferreiro J, Vander Borght S, Bittoun E, Gheysens O, Dierickx D et al (2017) Identification of distinct subgroups of EBV-positive post-transplant diffuse large B-cell lymphoma. Mod Pathol 30(3):370\u2013381. \n                    https:\/\/doi.org\/10.1038\/modpathol.2016.199","journal-title":"Mod Pathol"},{"key":"2273_CR35","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1182\/blood.V124.21.2989.2989","volume":"124","author":"A Sato","year":"2014","unstructured":"Sato A, Yamakawa N, Okuyama K, Kotani A, Nakamura N, Ando K (2014) The critical interaction between Epstein-Barr virus (EBV) positive B-cells and tumor associated macrophages (TAMs). Blood 124:2989","journal-title":"Blood"},{"issue":"7203","key":"2273_CR36","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454(7203):436\u2013444. \n                    https:\/\/doi.org\/10.1038\/nature07205","journal-title":"Nature"},{"key":"2273_CR37","doi-asserted-by":"publisher","unstructured":"Park S, Lee J, Ko YH, Han A, Jun HJ, Lee SC et al (2007) The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma. Blood 110(3):972\u2013978. \n                    https:\/\/doi.org\/10.1182\/blood-2007-01-067769","DOI":"10.1182\/blood-2007-01-067769"},{"issue":"2","key":"2273_CR38","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3324\/haematol.2014.113472","volume":"100","author":"S Riihijarvi","year":"2015","unstructured":"Riihijarvi S, Fiskvik I, Taskinen M, Vajavaara H, Tikkala M, Yri O et al (2015) Prognostic influence of macrophages in patients with diffuse large B-cell lymphoma: a correlative study from a Nordic phase II trial. Haematologica 100(2):238\u2013245. \n                    https:\/\/doi.org\/10.3324\/haematol.2014.113472","journal-title":"Haematologica"},{"issue":"11","key":"2273_CR39","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/j.leukres.2014.09.007","volume":"38","author":"C Marinaccio","year":"2014","unstructured":"Marinaccio C, Ingravallo G, Gaudio F, Perrone T, Nico B, Maoirano E et al (2014) Microvascular density, CD68 and tryptase expression in human diffuse large B-cell lymphoma. Leuk Res 38(11):1374\u20131377. \n                    https:\/\/doi.org\/10.1016\/j.leukres.2014.09.007","journal-title":"Leuk Res"},{"issue":"1","key":"2273_CR40","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1309\/AJCPJX4BJV9NLQHY","volume":"135","author":"PN Meyer","year":"2011","unstructured":"Meyer PN, Fu K, Greiner T, Smith L, Delabie J, Gascoyne R et al (2011) The stromal cell marker SPARC predicts for survival in patients with diffuse large B-cell lymphoma treated with rituximab. Am J Clin Pathol 135(1):54\u201361. \n                    https:\/\/doi.org\/10.1309\/AJCPJX4BJV9NLQHY","journal-title":"Am J Clin Pathol"},{"issue":"8","key":"2273_CR41","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/j.1440-1827.02268.x","volume":"58","author":"S Hasselblom","year":"2008","unstructured":"Hasselblom S, Hansson U, Sigurdardottir M, Nilsson-Ehle H, Ridell B, Andersson PO (2008) Expression of CD68 + tumor-associated macrophages in patients with diffuse large B-cell lymphoma and its relation to prognosis. Pathol Int 58(8):529\u2013532. \n                    https:\/\/doi.org\/10.1111\/j.1440-1827.02268.x","journal-title":"Pathol Int"},{"issue":"3","key":"2273_CR42","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3324\/haematol.2014.110189","volume":"100","author":"R Coutinho","year":"2015","unstructured":"Coutinho R, Clear AJ, Mazzola E, Owen A, Greaves P, Wilson A et al (2015) Revisiting the immune microenvironment of diffuse large B-cell lymphoma using a tissue microarray and immunohistochemistry: robust semi-automated analysis reveals CD3 and FoxP3 as potential predictors of response to R-CHOP. Haematologica 100(3):363\u2013369. \n                    https:\/\/doi.org\/10.3324\/haematol.2014.110189","journal-title":"Haematologica"},{"issue":"2","key":"2273_CR43","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/hon.2142","volume":"33","author":"F Marchesi","year":"2015","unstructured":"Marchesi F, Cirillo M, Bianchi A, Gately M, Olimpieri OM, Cerchiara E et al (2015) High density of CD68+\/CD163 + tumour-associated macrophages (M2-TAM) at diagnosis is significantly correlated to unfavorable prognostic factors and to poor clinical outcomes in patients with diffuse large B-cell lymphoma. Hematol Oncol 33(2):110\u2013112. \n                    https:\/\/doi.org\/10.1002\/hon.2142","journal-title":"Hematol Oncol"},{"issue":"2","key":"2273_CR44","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1365-2559.2011.04096.x","volume":"60","author":"N Wada","year":"2012","unstructured":"Wada N, Zaki MA, Hori Y, Hashimoto K, Tsukaguchi M, Tatsumi Y et al (2012) Tumour-associated macrophages in diffuse large B-cell lymphoma: a study of the Osaka Lymphoma Study Group. Histopathology 60(2):313\u2013319. \n                    https:\/\/doi.org\/10.1111\/j.1365-2559.2011.04096.x","journal-title":"Histopathology"},{"key":"2273_CR45","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.humpath.2017.04.012","volume":"64","author":"J Jeong","year":"2017","unstructured":"Jeong J, Oh EJ, Yang WI, Kim SJ, Yoon SO (2017) Implications of infiltrating immune cells within bone marrow of patients with diffuse large B-cell lymphoma. Hum Pathol 64:222\u2013231. \n                    https:\/\/doi.org\/10.1016\/j.humpath.2017.04.012","journal-title":"Hum Pathol"},{"issue":"17","key":"2273_CR46","doi-asserted-by":"publisher","first-page":"7113","DOI":"10.1073\/pnas.0902636106","volume":"106","author":"RM O\u2019Connell","year":"2009","unstructured":"O\u2019Connell RM, Chaudhuri AA, Rao DS, Baltimore D (2009) Inositol phosphatase SHIP1 is a primary target of miR-155. Proc Natl Acad Sci USA 106(17):7113\u20137118. \n                    https:\/\/doi.org\/10.1073\/pnas.0902636106","journal-title":"Proc Natl Acad Sci USA"},{"issue":"40","key":"2273_CR47","doi-asserted-by":"publisher","first-page":"38628","DOI":"10.1074\/jbc.M305021200","volume":"278","author":"CP Baran","year":"2003","unstructured":"Baran CP, Tridandapani S, Helgason CD, Humphries RK, Krystal G, Marsh CB (2003) The inositol 5\u2032-phosphatase SHIP-1 and the Src kinase Lyn negatively regulate macrophage colony-stimulating factor-induced Akt activity. J Biol Chem 278(40):38628\u201338636. \n                    https:\/\/doi.org\/10.1074\/jbc.M305021200","journal-title":"J Biol Chem"},{"issue":"7","key":"2273_CR48","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1091\/mbc.E11-10-0889","volume":"23","author":"S Mondal","year":"2012","unstructured":"Mondal S, Subramanian KK, Sakai J, Bajrami B, Luo HR (2012) Phosphoinositide lipid phosphatase SHIP1 and PTEN coordinate to regulate cell migration and adhesion. Mol Biol Cell 23(7):1219\u20131230. \n                    https:\/\/doi.org\/10.1091\/mbc.E11-10-0889","journal-title":"Mol Biol Cell"},{"issue":"11","key":"2273_CR49","doi-asserted-by":"publisher","first-page":"e7919","DOI":"10.1371\/journal.pone.0007919","volume":"4","author":"MV Rajaram","year":"2009","unstructured":"Rajaram MV, Butchar JP, Parsa KV, Cremer TJ, Amer A, Schlesinger LS et al (2009) Akt and SHIP modulate Francisella escape from the phagosome and induction of the Fas-mediated death pathway. PLoS One 4(11):e7919. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0007919","journal-title":"PLoS One"},{"issue":"5","key":"2273_CR50","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.semcancer.2008.03.004","volume":"18","author":"A Sica","year":"2008","unstructured":"Sica A, Larghi P, Mancino A, Rubino L, Porta C, Totaro MG et al (2008) Macrophage polarization in tumour progression. Semin Cancer Biol 18(5):349\u2013355. \n                    https:\/\/doi.org\/10.1016\/j.semcancer.2008.03.004","journal-title":"Semin Cancer Biol"},{"issue":"2","key":"2273_CR51","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.coi.2010.01.009","volume":"22","author":"A Mantovani","year":"2010","unstructured":"Mantovani A, Sica A (2010) Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr Opin Immunol 22(2):231\u2013237. \n                    https:\/\/doi.org\/10.1016\/j.coi.2010.01.009","journal-title":"Curr Opin Immunol"},{"key":"2273_CR52","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/pathogens7020040","volume":"7","author":"G Tan","year":"2018","unstructured":"Tan G, Visser L, Tan L, Berg A, Diepstra A (2018) The microenvironment in Epstein\u2013Barr virus-associated malignancies. Pathogens 7:2. \n                    https:\/\/doi.org\/10.3390\/pathogens7020040","journal-title":"Pathogens"},{"issue":"22","key":"2273_CR53","doi-asserted-by":"publisher","first-page":"11670","DOI":"10.1128\/JVI.01248-10","volume":"84","author":"SD Linnstaedt","year":"2010","unstructured":"Linnstaedt SD, Gottwein E, Skalsky RL, Luftig MA, Cullen BR (2010) Virally induced cellular microRNA miR-155 plays a key role in B-cell immortalization by Epstein-Barr virus. J Virol 84(22):11670\u201311678. \n                    https:\/\/doi.org\/10.1128\/JVI.01248-10","journal-title":"J Virol"},{"issue":"11","key":"2273_CR54","doi-asserted-by":"publisher","first-page":"5295","DOI":"10.1128\/JVI.02380-07","volume":"82","author":"Q Yin","year":"2008","unstructured":"Yin Q, McBride J, Fewell C, Lacey M, Wang X, Lin Z et al (2008) MicroRNA-155 is an Epstein-Barr virus-induced gene that modulates Epstein-Barr virus-regulated gene expression pathways. J Virol 82(11):5295\u20135306. \n                    https:\/\/doi.org\/10.1128\/JVI.02380-07","journal-title":"J Virol"},{"issue":"20","key":"2273_CR55","doi-asserted-by":"publisher","first-page":"6608","DOI":"10.1093\/nar\/gkn666","volume":"36","author":"G Gatto","year":"2008","unstructured":"Gatto G, Rossi A, Rossi D, Kroening S, Bonatti S, Mallardo M (2008) Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathway. Nucleic Acids Res 36(20):6608\u20136619. \n                    https:\/\/doi.org\/10.1093\/nar\/gkn666","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"2273_CR56","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1097\/SHK.0000000000000604","volume":"46","author":"K Essandoh","year":"2016","unstructured":"Essandoh K, Li Y, Huo J, Fan GC (2016) MiRNA-mediated macrophage polarization and its potential role in the regulation of inflammatory response. Shock 46(2):122\u2013131. \n                    https:\/\/doi.org\/10.1097\/SHK.0000000000000604","journal-title":"Shock"},{"key":"2273_CR57","doi-asserted-by":"publisher","first-page":"37446","DOI":"10.1038\/srep37446","volume":"6","author":"L Lu","year":"2016","unstructured":"Lu L, McCurdy S, Huang S, Zhu X, Peplowska K, Tiirikainen M et al (2016) Time series miRNA-mRNA integrated analysis reveals critical miRNAs and targets in macrophage polarization. Sci Rep 6:37446. \n                    https:\/\/doi.org\/10.1038\/srep37446","journal-title":"Sci Rep"},{"issue":"1","key":"2273_CR58","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10753-017-0672-8","volume":"41","author":"P Zhang","year":"2018","unstructured":"Zhang P, Wang H, Luo X, Liu H, Lu B, Li T et al (2018) MicroRNA-155 inhibits polarization of macrophages to M2-type and suppresses choroidal neovascularization. Inflammation 41(1):143\u2013153. \n                    https:\/\/doi.org\/10.1007\/s10753-017-0672-8","journal-title":"Inflammation"},{"issue":"20","key":"2273_CR59","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R et al (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127(20):2375\u20132390. \n                    https:\/\/doi.org\/10.1182\/blood-2016-01-643569","journal-title":"Blood"},{"key":"2273_CR60","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/1479-5876-9-177","volume":"9","author":"TL Rogers","year":"2011","unstructured":"Rogers TL, Holen I (2011) Tumour macrophages as potential targets of bisphosphonates. J Transl Med 9:177. \n                    https:\/\/doi.org\/10.1186\/1479-5876-9-177","journal-title":"J Transl Med"},{"issue":"4","key":"2273_CR61","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1158\/1535-7163.MCT-07-0579","volume":"7","author":"NR Miselis","year":"2008","unstructured":"Miselis NR, Wu ZJ, Van Rooijen N, Kane AB (2008) Targeting tumor-associated macrophages in an orthotopic murine model of diffuse malignant mesothelioma. Mol Cancer Ther 7(4):788\u2013799. \n                    https:\/\/doi.org\/10.1158\/1535-7163.MCT-07-0579","journal-title":"Mol Cancer Ther"},{"key":"2273_CR62","unstructured":"Clinical Trials NCT02637531 (2017) \n                    https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02637531>\n                    \n                  . Accessed 18 Jul 2017"},{"issue":"7629","key":"2273_CR63","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nature19834","volume":"539","author":"MM Kaneda","year":"2016","unstructured":"Kaneda MM, Messer KS, Ralainirina N, Li H, Leem CJ, Gorjestani S et al (2016) PI3Kgamma is a molecular switch that controls immune suppression. Nature 539(7629):437\u2013442. \n                    https:\/\/doi.org\/10.1038\/nature19834","journal-title":"Nature"},{"issue":"7629","key":"2273_CR64","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nature20554","volume":"539","author":"O Henau De","year":"2016","unstructured":"De Henau O, Rausch M, Winkler D, Campesato LF, Liu C, Cymerman DH et al (2016) Overcoming resistance to checkpoint blockade therapy by targeting PI3Kgamma in myeloid cells. Nature 539(7629):443\u2013447. \n                    https:\/\/doi.org\/10.1038\/nature20554","journal-title":"Nature"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-018-2273-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-018-2273-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-018-2273-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T20:55:40Z","timestamp":1581972940000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-018-2273-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,14]]},"references-count":64,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["2273"],"URL":"https:\/\/doi.org\/10.1007\/s00262-018-2273-2","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,14]]},"assertion":[{"value":"6 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the ethical committees of all collaborating centers: Department of Clinical and Experimental Oncology, Universidade Federal de S\u00e3o Paulo, Brazil; Department of Physiology, Universidade Federal de S\u00e3o Paulo, Brazil; Department of Pathology, AC Camargo Cancer Center, Brazil; Department of Pathology, Universidade Federal de S\u00e3o Paulo, Brazil; Molecular Oncology Research Center, Barretos Cancer Hospital, Brazil; Faculty of Medical Sciences of Santa Casa of S\u00e3o Paulo; Department of Pathology, Universidade de S\u00e3o Paulo, Brazil, and was in accordance with the ethical standards of the institutional committees and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}